Urology Medical News about Renal Allografts

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Three-Month Experience With Tacrolimus Once-Daily Regimen in Stable Renal Allografts
Transplantation Proceedings, 09/17/09

Ojea BD et al. – Based on a milligram–for–milligram conversion, only 7.6% of our patients required a dose adjustment. With this conversion, an initial decrease in tacrolimus trough levels was documented at day 7, which remained stable to the end of the study. The patients needed a lower number of capsules. These results supported the safety of MR–4.

<< Previous
Treatment With Cinacalcet of Secondary Hyperparathyroidism After...

Next >>
En Bloc Retroperitoneal Pancreas-Kidney Transplantation With...

Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09 Relevance Score: 69%%

The Prevalence of C4d-Positive Renal Allografts in 134 Consecutive Biopsies in Thai Patients
Transplantation Proceedings, 11/23/09 Relevance Score: 68%%

Antibody-mediated rejection of renal allograft in combined liver–kidney transplant
Clinical Transplantation, 11/20/09 Relevance Score: 68%%

Genetic Polymorphisms of Immunoregulatory Proteins in Acute Renal Allograft Rejection
Transplantation Proceedings, 11/10/09 Relevance Score: 68%%

Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09 Relevance Score: 67%%